Cargando…

Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma

Detalles Bibliográficos
Autores principales: Chapman, Kenneth R., Watz, Henrik, Singh, Dave, Hohlfeld, Jens M., Diamant, Zuzana, Jones, Ieuan, Tillmann, Hanns-Christian, Nikolaev, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149339/
https://www.ncbi.nlm.nih.gov/pubmed/33864631
http://dx.doi.org/10.1007/s40261-021-01033-6
_version_ 1783697940432289792
author Chapman, Kenneth R.
Watz, Henrik
Singh, Dave
Hohlfeld, Jens M.
Diamant, Zuzana
Jones, Ieuan
Tillmann, Hanns-Christian
Nikolaev, Ivan
author_facet Chapman, Kenneth R.
Watz, Henrik
Singh, Dave
Hohlfeld, Jens M.
Diamant, Zuzana
Jones, Ieuan
Tillmann, Hanns-Christian
Nikolaev, Ivan
author_sort Chapman, Kenneth R.
collection PubMed
description
format Online
Article
Text
id pubmed-8149339
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81493392021-06-01 Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma Chapman, Kenneth R. Watz, Henrik Singh, Dave Hohlfeld, Jens M. Diamant, Zuzana Jones, Ieuan Tillmann, Hanns-Christian Nikolaev, Ivan Clin Drug Investig Research Letter Springer International Publishing 2021-04-17 2021 /pmc/articles/PMC8149339/ /pubmed/33864631 http://dx.doi.org/10.1007/s40261-021-01033-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research Letter
Chapman, Kenneth R.
Watz, Henrik
Singh, Dave
Hohlfeld, Jens M.
Diamant, Zuzana
Jones, Ieuan
Tillmann, Hanns-Christian
Nikolaev, Ivan
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
title Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
title_full Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
title_fullStr Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
title_full_unstemmed Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
title_short Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
title_sort lung function normalisation with indacaterol acetate/glycopyrronium bromide/mometasone furoate in patients with asthma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149339/
https://www.ncbi.nlm.nih.gov/pubmed/33864631
http://dx.doi.org/10.1007/s40261-021-01033-6
work_keys_str_mv AT chapmankennethr lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT watzhenrik lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT singhdave lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT hohlfeldjensm lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT diamantzuzana lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT jonesieuan lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT tillmannhannschristian lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma
AT nikolaevivan lungfunctionnormalisationwithindacaterolacetateglycopyrroniumbromidemometasonefuroateinpatientswithasthma